Featured Article

Ukraine War’s Impact on Clinical Research: Evidence from Key Risk Indicators

Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable study teams to detect emerging quality issues of interest during a clinical trial. Given the large volume of KRI-related information now available for global clinical trials on the CluePoints risk-based quality management (RBQM) platform, we decided to take the opportunity to assess to what degree this KRI data provides evidence of the disruption of the war in Ukraine to clinical research being conducted there.

Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding
Press Release
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations